W43 (Rosiglitazone Maleate 8 mg (base))
Pill with imprint W43 is Red, Elliptical/Oval and has been identified as Rosiglitazone Maleate 8 mg (base). It is supplied by West-ward Pharmaceutical Corp.
Rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 8 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for W43
Rosiglitazone Maleate
- Imprint
- W43
- Strength
- 8 mg (base)
- Color
- Red
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Thiazolidinediones
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- West-ward Pharmaceutical Corp.
- National Drug Code (NDC)
- 00143-9975
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
titanium dioxide,
egg phospholipids,
polyethylene glycol 3350,
polyvinyl alcohol,
ferric oxide red,
sodium starch glycolate type A potato,
magnesium silicate
Note: Inactive ingredients may vary.
Related images for "W43"
More about rosiglitazone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (8)
- Imprints, shape & color data
- Drug class: thiazolidinediones
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.